Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — Q1 2025 Earnings Presentation
15 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Apr 30, 2025
Slide 1: Q1 Conference Call
Q1 Conference Call Drägerwerk AG & Co. KGaA April 30, 2025, Lübeck
Slide 2: Disclaimer
Disclaimer — This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future
Slide 3: Agenda
Agenda — 01 Dräger Business Highlights 02 Financials Q1 2025 03 Outlook FY 2025 Drägerwerk AG & Co. KGaA 3
Slide 4: Dräger Business Highlights
01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4
Slide 5: Q1 2025 Highlights
Q1 2025 Highest Q1 demand Stable net sales – positive since record year 2020 EBIT – higher cash flow Highlights Continued good demand: highest Q1 order intake since the record- breaking year 2020; growth in both Robust sales development: divisions Net sales EBIT net sales almost reaching the high le
Slide 6: Financials Q1 2025
02 Financials Q1 2025 Drägerwerk AG & Co. KGaA 6
Slide 7: Business development Group
Business development Group Order entry Q1 2024 Q1 2025 Change — (€ million) (fx-adj.) Germany 212.1 196.4 -7.4 EMEA 312.0 355.3 +13.1 Net sales (€ million) Americas 160.4 172.4 +8.7 -1.2% APAC 126.3 136.8 +7.8 fx-adj -0.8% Total 810.8 860.8 +6.1 nominal 736 730 • Order entry clearly above high prior
Slide 8: Business development Medical
Business development Medical Order entry Q1 2024 Q1 2025 Change — (€ million) (fx-adj.) Germany 108.2 105.6 -2.4 EMEA 159.4 176.0 +9.2 Net sales (€ million) Americas 106.9 104.9 -0.3 -1.6% APAC 79.2 87.3 +9.5 fx-adj -1.0% Total 453.7 473.7 +4.2 nominal 417 413 • Order entry higher after a decline in
Slide 9: Business development Safety
Business development Safety Order entry Q1 2024 Q1 2025 Change — (€ million) (fx-adj.) Germany 104.0 90.8 -12.7 EMEA 152.6 179.3 +17.2 Net sales (€ million) Americas 53.5 67.5 +26.9 -0.6% APAC 47.1 49.6 +5.0 fx-adj -0.4% Total 357.2 387.1 +8.4 nominal 318 317 • Order entry clearly above prior-year l
Slide 10: Key figures
Key figures Q1 2025 Q1 2024 Change € million € million % Cashflow (from operating activities) 55.9 33.5 +66.8 Investments 28.9 22.7 +26.9 Cash and cash equivalents1 249.6 211.7 +17.9 Net financial debt1 141.8 193.5 -26.7 Net financial debt1 / EBITDA2 0.4 0.6 Capital employed 1 1,554.6 1,526.5 +1.8 R
Slide 11: Outlook FY 2025
03 Outlook FY 2025 Drägerwerk AG & Co. KGaA 11
Slide 12: Outlook
Outlook Results achieved Forecast for for fiscal year 2024 fiscal year 20251 Net sales (net of currency effects) 0.5% 1.0 to 5.0% EBIT margin 5.8% 3.5 to 6.5% Dräger Value Added (DVA) EUR 54.3 million EUR -30 to 80 million 1 The potential impact of US customs policy on our business performance is no
Slide 13: Questions & Answers
Questions & Answers Drägerwerk AG & Co. KGaA 13
Slide 14: Financial calendar
Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 31, 2025 Annual Report 2024 Conference call April 30, 2025 Report for the first three months 2025 Conference
Slide 15: Thank you
Thank you Thomas Fischler Nikolaus Hammerschmidt Head of Treasury & Investor Relations Investor Relations Manager Moislinger Alle 53-55 Moislinger Alle 53-55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel. +49 451 882 2685 Tel. +49 451 882 8903 Mail: thomas.fischler@draeger.com Mail: nikolaus.hamme
Drägerwerk AG & Co. KGaA — Q1 2025 Earnings Presentation on 6ix